Questionnaire to reduce the risk of iatrogenic prion disease transmission [1]

Journal of Hospital Infection

Volumn 60, Issue 4, 2005, Pages 378-379

  Mead, S ^a   Prout, K ^a   Collinge, J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HYPOPHYSIS HORMONE;

BLOOD TRANSFUSION; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; HEALTH CARE POLICY; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; IATROGENIC DISEASE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LETTER; MICROBIAL CONTAMINATION; NATIONAL HEALTH SERVICE; NEUROSURGERY; PRION DISEASE; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURGICAL INSTRUMENT; TISSUE DISTRIBUTION; VIRULENCE; VIRUS VIRULENCE;

HUMANS; IATROGENIC DISEASE; PRION DISEASES; QUESTIONNAIRES;

EID: 21644477102     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.02.003     Document Type: Letter

References (6)

1. P. Brown M. Preece J.P. Brandel et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium Neurology 55 2000 1075-1081
2. J.D.F. Wadsworth S. Joiner A.F. Hill et al. Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay Lancet 358 2001 171-180
3. Department of Health Transmissible spongiform encephalopathy agents: safe working and the prevention of infection 2003 Department of Health London
4. C.A. Llewelyn P.E. Hewitt R.S. Knight et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion Lancet 363 2004 417-421
5. A.H. Peden M.W. Head D.L. Ritchie J.E. Bell J.W. Ironside Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient Lancet 364 2004 527-529
6. J.K. Struthers M.J. Weinbren J. Lockwood S. Glancy N.H. O'Connell Risk assessment for Creutzfeldt-Jakob disease Lancet 360 2002 1026